In an effort to expand the deceased donor pool, transplant centers have accepted expanded criteria donors as appropriate for many of the patients in the deceased donor pool. Translating this into the living donor pool is more complex. One must consider not only the quality of the organ procured but the consequences that the nephrectomy might have on the living donors for the rest of their lives. This review examines the available data on higher risk donors and the appropriateness, or lack thereof, of accepting them as kidney donors.
McCulloughKPKeithDSMeyerKH. Kidney and pan*creas transplantation in the United States, 1998–2007: Access for patients with diabetes and end-stage renal disease. Am J Transplant.2009;9(4 pt 2):894–906.
ReesePPFeldmanHIMcBrideMA. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant.2008; 8(10):2062–2070.
6.
DolsLFKokNFRoodnatJI. Living kidney donors: Impact of age on long-term safety. Am J Transplant.2011; 11(4):737–742.
7.
JacobsSCRameyJRSklarGN. Laparoscopic kidney donation from patients older than 60 years. J Am Coll Surg.2004;198(6):892–897.
MagnussenEBVattenLJSmithGD. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol.2009;114(5):961–970.
11.
LeonciniGRattoEViazziF. Global risk stratification in primary hypertension: The role of the kidney. J Hypertens.2008;26(3):427–432.
12.
CerasolaGMuleGNardiE. Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: The REDHY study. J Hum Hypertens.2010;24(1):44–50.
13.
TextorSTalerS. Expanding criteria for living kidney donors: What are the limits?Transplant Rev.2008;22(3):187–191.
14.
HsuCY. Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective. Curr Opin Nephrol Hypertens.2002;11(3):267–272.
15.
SteinerRW. ‘Normal for now,’ or ‘at future risk’: A double standard for selecting young and older living kidney donors. Am J Transplant.2010;10(4):737–741.
16.
TextorSCTalerSJDriscollN. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation.2004;78(2):276–282.
17.
HsuCYMcCullochCEIribarrenC. Body mass index and risk for end-stage renal disease. Ann Intern Med.2006; 144(1):21–28.
18.
HeimbachJKTalerSJPrietoM. Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant.2005; 5(5):1057–1064.
19.
TavakolMMVincentiFGAssadiH. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol2009;4(7):1230–1238.
20.
BurgherABermanMHoltzmanJL. Progression of nephrolithiasis: Long-term outcomes with observation of asymptomatic calculi. J Endourol.2004;18(6):534–539.
21.
LeeYHHuangWCChangLS. The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. J Urol.1994;152(5):1386–1388.
22.
WorcesterEParksJHJosephsonMA. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int.2003;64(6):2204–2213.
23.
KidoRShibagakiYIwadohK. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant.2010;10(7):1597–1604.
24.
KoushikRGaarveyCManivelJC. Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation.2005;80(10):1425–1429.
25.
WeijnenCFRichSSMeigsJB. Risk of diabetes in siblings of index cases with Type 2 diabetes: Implications for genetic studies. Diabet Med.2002;19(1):41–50.
WilsonPWMeigsJBSullivanL. Prediction of incident diabetes mellitus in middle middle-aged adults: The Framingham Offspring Study. Arch Intern Med.2007;167(10):1068–1074.
28.
KahnHSChengYJThompsonTJ. Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 years. Ann Intern Med.2009;150(11):741–751.
29.
AdlerAIStevensRJManleySE. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int.2003;63(1):225–232.
30.
CrookEDPatelSR. Diabetic nephropathy in African American populations. Curr Diab Rep.2004;4(6):455–461.
31.
OkamotoMSuzukiTFujikiM. The consequences for live donors with preexisting glucose intolerance without diabetic complication: Analysis at a single Japanese center. Transplantation.2010;89(11): 1391–1395.
32.
LentineKLSchnitzlerMAXiaoH. Racial variation in medical outcomes among living kidney donors. N Engl J Med.2010;368363(8):724–732.
33.
NogueiraJMWeirMRJacobsS. A study of renal outcomes in African American living kidney donors. Transplantation.2009;88(12):1371–1376.
34.
BiglarniaABergqvistDJohanssonMWadströmJ. Venous thromboembolism in live kidney donors—a prospective study. Transplantation.2008;86(5):659–661.
35.
TysonMDCastleEPKoEY. Living donor kidney transplantation with multiple arteries in the laparoscopic era. Urology.2011;77(5): 1116–1121.
36.
MillisMASimmerlingM. Prisoners as organ donors: Is it worth the effort? Is it ethical?Transplant Proc.2009;41(1):23–24.
37.
IbrahimHNFoleyRTanL. Long-term consequences of kidney donation. N Engl J Med.2009;360(5):459–469.
